Relief Therapeutics Holding AG (RLFTF)

[aGuyUS]

@Insightfulpenguin

Trial site news 10/15/2020 even states 9 Fold advantage, I am beginning to think Trial site news isn't News at all as they don't track their own publications, and report on discrepancies. Honestly this deserves a lot of letters to Trial site news asking questions

10/15 Article- Stating "9 fold" survival rates https://www.trialsitenews.com/rlf-100-expanded-access-program-at-houston-methodist-hospital-9-fold-increased-probability-of-survival-from-critical-covid-19/

Versus 11/1/2020 that is reporting only "3 Fold Advantage in survival" Here https://www.trialsitenews.com/neurorx-submits-request-for-emergency-use-authorization-for-rlf-100-in-treatment-of-covid-19-patients-with-respiratory-failure-no-other-recourse/

The 11/1/2020 Trialsite Article 11/1/2020 (TOday) matches with the Older PR on 9/23/2020 reported by relief therapeutics here https://relieftherapeutics.com/newsblog/110-relief-partner-neurorx-submits-request-for-emergency-use-authorization-for-rlf-100-aviptadil-in-the-treatment-of-patients-with-critical-covid-19-and-respiratory-failure-who-have-exhausted-approved-therapy


I personally do not feel there is anything fishy about it, except very badly done Reporting on Clinical trial status